Reckitt Benckiser Group Plc (RBGPF.PK) Q2 2010 Earnings Call July 26, 2010 08:00 am ET Executives Colin Day - CFO Bart Becht - CEO Analysts Mark Christensen - Morgan Stanley Celine Pannuti - JPMorgan Susanne Seibel - Barclays Capital Pablo Zuanic - Liberum Capital Rosie Edwards - Goldman Sachs Eamonn Ferry - Exane BNP Paribas Gustavo Pifano - Gabelli & Company Warren Ackerman - Evolution Securities Xavier Croquez - Cheuvreux Debra Aitken - Bryan Garnier Alex Smith - Nomura Simon Marshall Lockyer - Jefferies Richard Taylor - Morgan Stanley Chas Manso - Evolution Securities Presentation
Good morning and welcome to Reckitt Benckiser first or half year presentation with results. I'm going to give you a quick overview and then I'm going to handover to Colin Day our CFO who will take you through the details of the results after which I will come back to take you through our key initiatives for the second half and then I'm going to make some final comments about SSL, the subject on which we will take very, very few questions because we are bound by the takeover code. So don't take it as rude, we simply cannot answer practically any question on this subject. So quick summary, total business continues to perform very strongly, you've seen the result. Reckitt Benckiser Pharmaceuticals the half year performance was fully inline with the full year financial targets. We believe this is a very strong performance considering we set the targets in the context of a market growth rate of 4% and on year-to-date basis the market growth rate barely makes to 2%. So net we are now growing at over double the global market growth rate.